The AHI-1 (abelson helper integration site 1) oncogene might also be a potential LSC target since it appears over-expressed in CML stem cells and enhance BCR-ABL effect on cell growth [77]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.